These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22326437)

  • 21. Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells.
    Eisenreich A; Zakrzewicz A; Huber K; Thierbach H; Pepke W; Goldin-Lang P; Schultheiss HP; Pries A; Rauch U
    Oncol Rep; 2013 Jul; 30(1):462-70. PubMed ID: 23604472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors.
    Lewis CS; Elnakat Thomas H; Orr-Asman MA; Green LC; Boody RE; Matiash K; Karve A; Hisada YM; Davis HW; Qi X; Mercer CA; Lucas FV; Aronow BJ; Mackman N; Versteeg HH; Bogdanov VY
    J Thromb Haemost; 2019 Jan; 17(1):169-182. PubMed ID: 30472780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells.
    Fang J; Gu L; Zhu N; Tang H; Alvarado CS; Zhou M
    BMC Cancer; 2008 Mar; 8():69. PubMed ID: 18325115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of murine alternatively spliced tissue factor.
    Bogdanov VY; Kirk RI; Miller C; Hathcock JJ; Vele S; Gazdoiu M; Nemerson Y; Taubman MB
    J Thromb Haemost; 2006 Jan; 4(1):158-67. PubMed ID: 16409465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
    Wang Y; Wang X; Zhao H; Liang B; Du Q
    J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IKK beta is required for Bcl-2-mediated NF-kappa B activation in ventricular myocytes.
    Regula KM; Ens K; Kirshenbaum LA
    J Biol Chem; 2002 Oct; 277(41):38676-82. PubMed ID: 12167626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update.
    Matiash K; Lewis CS; Bogdanov VY
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling.
    Giannarelli C; Alique M; Rodriguez DT; Yang DK; Jeong D; Calcagno C; Hutter R; Millon A; Kovacic JC; Weber T; Faries PL; Soff GA; Fayad ZA; Hajjar RJ; Fuster V; Badimon JJ
    Circulation; 2014 Oct; 130(15):1274-86. PubMed ID: 25116956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SOCS-1 inhibits TNF-alpha-induced cardiomyocyte apoptosis via ERK1/2 pathway activation.
    Yan L; Tang Q; Shen D; Peng S; Zheng Q; Guo H; Jiang M; Deng W
    Inflammation; 2008 Jun; 31(3):180-8. PubMed ID: 18330685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-kappaB, activation protein-1, and c-Jun N-terminal kinase.
    Manna SK; Haridas V; Aggarwal BB
    J Interferon Cytokine Res; 2000 Aug; 20(8):725-35. PubMed ID: 10954916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis-modulating interaction of the neuregulin/erbB pathway with anthracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes.
    Rohrbach S; Muller-Werdan U; Werdan K; Koch S; Gellerich NF; Holtz J
    J Mol Cell Cardiol; 2005 Mar; 38(3):485-93. PubMed ID: 15733908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3,3'-Diindolylmethane protects cardiomyocytes from LPS-induced inflammatory response and apoptosis.
    Luo Q; Yang A; Cao Q; Guan H
    BMC Pharmacol Toxicol; 2018 Nov; 19(1):71. PubMed ID: 30413180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic fibroblast growth factor selectively enhances TNF-alpha-induced apoptotic cell death in glomerular endothelial cells: effects on apoptotic signaling pathways.
    Messmer UK; Briner VA; Pfeilschifter J
    J Am Soc Nephrol; 2000 Dec; 11(12):2199-2211. PubMed ID: 11095643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue factor isoforms in cancer and coagulation: may the best isoform win.
    Kocatürk B; Versteeg HH
    Thromb Res; 2012 Apr; 129 Suppl 1():S69-75. PubMed ID: 22682138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutaredoxin regulates apoptosis in cardiomyocytes via NFkappaB targets Bcl-2 and Bcl-xL: implications for cardiac aging.
    Gallogly MM; Shelton MD; Qanungo S; Pai HV; Starke DW; Hoppel CL; Lesnefsky EJ; Mieyal JJ
    Antioxid Redox Signal; 2010 Jun; 12(12):1339-53. PubMed ID: 19938943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCL-XL regulates TNF-alpha-mediated cell death independently of NF-kappaB, FLIP and IAPs.
    Gozzelino R; Sole C; Llecha N; Segura MF; Moubarak RS; Iglesias-Guimarais V; Perez-Garcia MJ; Reix S; Zhang J; Badiola N; Sanchis D; Rodriguez-Alvarez J; Trullas R; Yuste VJ; Comella JX
    Cell Res; 2008 Oct; 18(10):1020-36. PubMed ID: 18591962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.
    Guha M; O'Connell MA; Pawlinski R; Hollis A; McGovern P; Yan SF; Stern D; Mackman N
    Blood; 2001 Sep; 98(5):1429-39. PubMed ID: 11520792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternatively spliced tissue factor: discovery, insights, clinical implications.
    Srinivasan R; Bogdanov VY
    Front Biosci (Landmark Ed); 2011 Jun; 16(8):3061-71. PubMed ID: 21622222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.